Predictors of Placebo Response to Local (Intra‐Articular) Therapy In Osteoarthritis: An Individual Participant Data Meta‐Analysis

Abstract

ObjectiveWe undertook this study to evaluate potential predictors of placebo response with intra‐articular (IA) injections for knee/hip osteoarthritis (OA) using individual participant data (IPD) from existing trials.MethodsRandomized placebo‐controlled trials evaluating IA glucocorticoid or hyaluronic acid published to September 2018 were selected. IPD for disease characteristics and outcome measures were acquired. Potential predictors of placebo response included participant characteristics, pain severity, intervention, and trial design. Placebo response was defined as at least a 20% reduction in baseline pain. Logistic regression models and odds ratios were computed as effect measures to evaluate patient and pain mechanisms and then pooled using a random effects model. Generalized mixed‐effect models were applied to intervention and trial characteristics.ResultsOf 56 eligible trials, 6 shared data, and these were combined with the existing 4 OA Trial Bank studies, yielding 10 studies with IPD of 621 placebo participants for analysis. In the total placebo population, at short‐term follow‐up, the use of local anesthetic and ultrasound guidance were associated with reduced odds of placebo response. At midterm follow‐up, mid‐ to long‐term trial duration was associated with increased odds of placebo response, and worse baseline function scores were associated with reduced odds of a placebo response.ConclusionThe administration of local anesthetics or ultrasound guidance may reduce IA placebo response at short‐term follow‐up. At midterm follow‐up, participants with worse baseline function scores may be less likely to respond to IA placebo, and mid‐ to long‐term trial duration may enhance the placebo response. Further studies are required to corroborate these potential predictors of IA placebo response.